Health Care·Health Care Distributors·$101.3B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.45 | N/A | -37.09% |
management commentary, guidance changes, and full analysis available with Pro.
| -37.09% |
Tone: Cautiously Optimistic
Overall, management expressed a cautious outlook, highlighting the need for continued focus on cost management and operational improvements.
Management acknowledged the challenges faced during the quarter.
They emphasized their commitment to improving operational efficiencies.
McKesson's earnings report showed a significant miss on EPS, which may raise concerns among investors about the company's profitability. However, the stock reacted positively, gaining 0.37%, possibly due to management's focus on operational efficiencies. Investors will be watching closely for future updates on performance and strategy.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
ALNYLAM PHARMACEUTIC
May 6, 2013